Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...

Philip Morris International Inc. (PM) stock saw a modest uptick, ending the day at $121.59 which represents a slight increase of $1.79 or 1.49% from the prior close of $119.8. The stock opened at $119 ...

Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...

We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Global leaders at the World Economic Forum in Davos have voiced urgent calls for Europe to rethink its economic and ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...

The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.

IQOS's success in Egypt signals a promising opportunity for the introduction of additional smoke-free products to the market, ...